Long-term Protection After Hepatitis B Vaccine

被引：54
作者：
Van Damme, Pierre [1 ]
机构：
[1] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium
来源：
JOURNAL OF INFECTIOUS DISEASES | 2016年 / 214卷 / 01期
关键词：
hepatitis B; vaccine; protection; duration; INFANT VACCINATION; EFFICACY; NEED; ELIMINATION;
D O I：
10.1093/infdis/jiv750
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [21] Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
    Ren, Wen
    Ren, Jingjing
    Wu, Zikang
    Shen, Lingzhi
    Shan, Huan
    Dai, Xuewei
    Li, Jing
    Liu, Ying
    Qiu, Yan
    Yao, Jun
    Li, Lanjuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 687 - 692
  • [22] Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel
    Kalchiem-Dekel, Or
    Grupel, Daniel
    Bouchnik, Lea
    Sikuler, Emanuel
    Ben-Yakov, Gil
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1782 - 1787
  • [23] Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
    Li, H.
    Li, G. J.
    Chen, Q. Y.
    Fang, Z. L.
    Wang, X. Y.
    Tan, C.
    Yang, Q. L.
    Wang, F. Z.
    Wang, F.
    Zhang, S.
    Bi, S. L.
    Shen, L. P.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (05) : 887 - 894
  • [24] Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients
    Yeh, Ming-Lun
    Huang, Ching-, I
    Huang, Chung-Feng
    Hsieh, Meng-Hsuan
    Liu, Ta-Wei
    Lin, Yi-Hung
    Liang, Po-Cheng
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Kuo, Po-Lin
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (08) : 1224 - 1233
  • [25] Long-term immunogenicity of single dose of live attenuated hepatitis A vaccine in Indian children
    Bhave, Sheila
    Sapru, Amita
    Bavdekar, Ashish
    Kapatkar, Vaibhavi
    Mane, Amey
    INDIAN PEDIATRICS, 2015, 52 (08) : 687 - 690
  • [26] Long-term Antibody Persistence in Children After Vaccination With the Pediatric Formulation of an Aluminum-free Virosomal Hepatitis A Vaccine
    Van Herck, Koen
    Hens, Annick
    De Coster, Ilse
    Vertruyen, Andre
    Tolboom, Jeroen
    Sarnecki, Michal
    Van Damme, Pierre
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (04) : E85 - E91
  • [27] Entecavir for the long-term treatment of chronic hepatitis B
    Gonzalez, Stevan A.
    Keeffe, Emmet B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (09) : 1053 - 1062
  • [28] Comparison of long-term immunogenicity (23 y) of 10 μg and 20 μg doses of hepatitis B vaccine in healthy children
    Wu, Qian
    Zhuang, Gui-hua
    Wang, Xue-liang
    Hou, Tie-jun
    Shah, Dimpy P.
    Wei, Xiao-li
    Wang, Li-rong
    Zhang, Min
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (08) : 1071 - 1076
  • [29] Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Nishikawa, Tomohiro
    Matsui, Masahiro
    Onishi, Saori
    Ushiro, Kosuke
    Asai, Akira
    Kim, Soo-Ki
    Nishikawa, Hiroki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [30] Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation
    Roche, B
    Samuel, D
    Gigou, M
    Feray, C
    Virot, V
    Majno, P
    Serraf, L
    David, MF
    Dusseaix, E
    Reynes, M
    Bismuth, H
    JOURNAL OF HEPATOLOGY, 1999, 31 (04) : 584 - 592
12345